GUGGENHEIM CAPITAL LLC - BIOPHARMX CORP ownership

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of BIOPHARMX CORP
ValueSharesWeighting
Q1 2018$7,000
+133.3%
30,424
+12.5%
0.00%
Q4 2017$3,000
-66.7%
27,047
-11.1%
0.00%
Q3 2017$9,000
-18.2%
30,425
+33.9%
0.00%
Q2 2017$11,0000.0%22,7180.0%0.00%
Q1 2017$11,00022,7180.00%
Other shareholders
BIOPHARMX CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 12,814,286$6,471,0001.90%
RTW INVESTMENTS, LP 1,283,951$648,0000.17%
Sio Capital Management, LLC 313,717$158,0000.09%
DAFNA Capital Management LLC 115,000$58,0000.05%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 28,027$14,0000.00%
Baker Brothers Advisors 377,295$191,0000.00%
Virtu KCG Holdings LLC 107,994$55,0000.00%
FRANKLIN RESOURCES INC 9,499,615$4,797,0000.00%
Moors & Cabot, Inc. 13,000$7,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 17,274$8,0000.00%
View complete list of BIOPHARMX CORP shareholders